Peder Møller Andersen

Biography

 Dr. Peder Møller Andersen, M.D., has been the Chief Operating Officer of Forward Pharma A/S since May 2012. Dr. Andersen also serves as Managing Director of Forward Pharma GmbH, Leipzig. He has been with Forward Pharma since 2009 in charge of the clinical development program for FP187. He served as the Chief Executive Officer of Forward Pharma A/S from August 4, 2014 to February 28, 2017. He had 6 years training in surgery, anesthesiology and internal medicine before joining the pharmaceutical industry in 1987. For over 25 years, he has worked for large Pharma industries like Sandoz in Copenhagen and Basel, for Novo Nordisk, for Orion in Denmark and Finland on clinical development projects. He has worked for CRO and for small biotech companies as external consultant. He has experience in several therapeutic areas and Orphan Drug development. He has been in multiple agency meetings both national, EMA and FDA. He has several years of Business Development experience, generic and proprietary on a European level with PLIVA, Croatia and AWD, Germany. He has successfully established and realized a Nordic based Pharma company. He served as a Director of Forward Pharma A/S. Dr. Andersen graduated from Copenhagen University, Medical school in 1981.

Research Interest

 generic and proprietary medicine